Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2006
05/17/2006CN1771942A Nizatidine injection and its prepn
05/17/2006CN1771941A Leflunomide dripping pill and its prepn
05/17/2006CN1771940A Ulcer treating Western medicine prepn and its prepn process
05/17/2006CN1771939A Indomethacin dripping pill and its prepn
05/17/2006CN1771938A Anethole trithione liposome and its prepn
05/17/2006CN1771937A Externally applied podophyllotoxin ointment and its prepn
05/17/2006CN1771936A Stable medicine composition of artemisinin or its derivative
05/17/2006CN1771935A Cremaster ketone prepn
05/17/2006CN1771934A Medicine composite containing red clover prime and prunetin and its medicinal application
05/17/2006CN1771933A Frusemide dripping pill and its prepn
05/17/2006CN1771932A Castor oil injection of low content polyethenoxy ether and ethanol injection of low content taxol
05/17/2006CN1771931A Use of diterpene compound in preparingmedicines with synergistic effect to chemical therepy medicines
05/17/2006CN1771930A Externally applied compound amino acid prepn for promoting wound healing and its prepn and application
05/17/2006CN1771929A Treatment of pcp addiction and pcp addiction-related behavior
05/17/2006CN1771928A Application of EDTA or its salt in slimming medicine
05/17/2006CN1771927A Calcium hydrophenyl sulfonate capsule and its prepn process
05/17/2006CN1771926A Application of diacyl thiourea derivative in preparing antiviral medicine
05/17/2006CN1771925A Application of recombinant allophycocyanin in preparing medicine for treating liver cancer
05/17/2006CN1771924A New Western medicine prepn for treating type-II diabetes
05/17/2006CN1771923A Propafenone hydrochloride dripping pill and its prepn
05/17/2006CN1771922A Ritodrine liposome and its prepn
05/17/2006CN1771921A Control releasing venlafaxine hydrochloride tablet and its prepn
05/17/2006CN1771920A Oral disintegrated sertraline tablet and its prepn
05/17/2006CN1771919A Compound soft lutein capsule and its prepn process
05/17/2006CN1771918A Granisetron cataplasm and its prepn
05/17/2006CN1771917A Prepn process of microcapsule with included anticancer medicine
05/17/2006CN1771915A Oral disintegrated Anfenmame tablet for treating children's cold and its prepn
05/17/2006CN1771914A Freeze dried polyene lecithin powder for injection and its prepn
05/17/2006CN1771911A Re-dispersible nanometer particle of insoluble medicine and its prepn
05/17/2006CN1771910A Nanometer particle of insoluble medicine and its prepn
05/17/2006CN1771909A Fatty artemisinin emulsion and its prepn and application
05/17/2006CN1771908A Dihydroergotoxine methanesulfonate transfused-fluid and its prepn
05/17/2006CN1771907A Analgetic capsicine rode and its making process
05/17/2006CN1771881A Quick identification method of the addication and dependance of opium drug addict
05/17/2006CN1256350C Water and oil soluble O-chitosan derivatives and their preparation and use
05/17/2006CN1256343C Chickweed total flavones , their production method , use and preparation containing the same
05/17/2006CN1256342C Acetamido glucose devicative of indomethacin and its synthetic method and use
05/17/2006CN1256337C Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene
05/17/2006CN1256336C Novel 4'-demethyl-4'-0-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for preparation thereof and anti-cancer composition comprising same
05/17/2006CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
05/17/2006CN1256333C Method for synthesizing saturated fatty acid vitamin C ester
05/17/2006CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method
05/17/2006CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/17/2006CN1256314C Non-cyclic 1,3-dicarbonyl PPAR double-activation compound with sugar-reducing lipid-reducing activity and preparation method of its medicinal preparation
05/17/2006CN1256308C Yew genus plant extract and its extraction method and application
05/17/2006CN1256138C Medicine for treating apoplexy and its preparing process
05/17/2006CN1256129C Acesodyne muscle regenerating paste for hemorrhoids
05/17/2006CN1256108C Ass-hide glue phosphotipid composition and its preparing method
05/17/2006CN1256106C Medicinally health-care powder made of ganoderma and lentinan
05/17/2006CN1256095C Method for preparing agent of cyclodextrin-cellulose for adsorbing uric acid
05/17/2006CN1256094C 3'-Deoxyadenosine in application of preparing bypolipidemic
05/17/2006CN1256093C Application of skimming in the preparing process of medicine for preventing and treating kidney function failure
05/17/2006CN1256092C Methyleritrocina injection
05/17/2006CN1256091C Adriacin or adriacin hydrochloride liposome injection and its preparing process
05/17/2006CN1256090C Application in antidepressants preparation of asiatic acid and derivative
05/17/2006CN1256089C Medicine for curing bed sore
05/17/2006CN1256088C 维生素c钠胶囊 Vitamin c sodium capsules
05/17/2006CN1256087C Application of aloelactone in preparation of medicine
05/17/2006CN1256086C Use of 5-hydroxymethyl furfural in preparation of drug for nerve system
05/17/2006CN1256085C Sertraline salts and substained-release dosage forms of sertraline
05/17/2006CN1256084C Applicaton of medicine for garlic oil anti radiation aleucocytosis reduction and DNA injury
05/17/2006CN1256082C Slow-released preparation
05/17/2006CN1256077C Beautifying face pack of pure Chinese herb for preventing face skin disease
05/16/2006USRE39096 Treatment of skin disorders
05/16/2006US7045683 Δ4-desaturase genes and uses thereof
05/16/2006US7045665 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like
05/16/2006US7045663 Comprises enantiomrph of ajoene such as Z(-)-4,5,9-trithiadodeca-1,6,11-triene-9-oxide for treating tissues/ improving condition for transplantation; gene expression inhibition; kits
05/16/2006US7045661 Crystalline forms of venlafaxine hydrochloride
05/16/2006US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor
05/16/2006US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives
05/16/2006US7045652 Processes for preparing substituted aryl boronic acids
05/16/2006US7045649 compounds are suitable, for example, for use as anorectics
05/16/2006US7045643 Method for obtaining novel lutein-based formulations
05/16/2006US7045636 MCH antagonists for the treatment of obesity
05/16/2006US7045633 Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
05/16/2006US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
05/16/2006US7045627 Reacting chloroperbenzoic acid with 3-dichloromethylthio-7-fluoro-1-,ethyl-4-quinolone in dichloromethane;
05/16/2006US7045626 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23
05/16/2006US7045621 Process for producing dibenzothiazepine derivatives
05/16/2006US7045620 Crystal structure antibiotic; heating, dissolving, crystallization
05/16/2006US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors
05/16/2006US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies
05/16/2006US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
05/16/2006US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
05/16/2006US7045594 Serine proteinase inhibitors
05/16/2006US7045576 Adjuvants and copolymer compositions
05/16/2006US7045551 such as (R)-N-[2-hydroxy-1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-propionamide; for treatment of migraines, bipolar disorders, epilepsy, acute/chronic pain and anxiety
05/16/2006US7045550 In situ administering; side effect reduction of cancer therapy
05/16/2006US7045549 Treatment of symptoms associated with irritable bowel syndrome
05/16/2006US7045548 Contacting with a C1 to C3 monohydroxy alcohol or C3 to C4 diol and a sufficient amount of an acid to adjust the pH to below 4.6; treating lesions associated with herpes infections
05/16/2006US7045547 Acyl-CoA dehydrogenase allenic inhibitors
05/16/2006US7045546 Stabilized derivatives of ascorbic acid-3-phosphate
05/16/2006US7045545 Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists
05/16/2006US7045544 Myocardium; angina pectoris
05/16/2006US7045543 Insertion drugs into cells, tissue; therapy for brain disorders, central nervous system disorders
05/16/2006US7045541 Compounds for the treatment of metabolic disorders
05/16/2006US7045540 Selective estrogen receptor modulators
05/16/2006US7045539 Therapeutic benzoxazole compounds
05/16/2006US7045538 Neurotransmitter moderator; analgesics; using n-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine